Eli Lilly's Mounjaro

Eli Lilly’s Mounjaro Secures Spot on China’s State Insurance List for Diabetes Care

The number of people living with diabetes in China is rising fast. On December 7, 2025, authorities announced that Eli Lilly’s Mounjaro, a weekly injectable diabetes drug, will be added to China’s state health insurance starting January 1, 2026.

Continue Reading on Meyka

This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.

Read Full Article →

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *